Sentence examples for markers as predictive from inspiring English sources
This paper evaluates the use of other tumor-related markers as predictive factors for adjuvant therapy.
Primary breast carcinomas treated with neoadjuvant chemotherapy or primary systemic therapy (PST) provide an ideal model to evaluate the role of biological markers as predictive and prognostic factors.
However, few studies have addressed this issue of cancer stem cell markers as predictive markers for pathologic responses and treatment outcome in rectal cancer [ 4, 11].
In addition, the area under the ROC curves of TNF-α and MMP-9 indicated good accuracy for both markers as predictive factors of sunitinib clinical benefit.
In spite of the fact that many studies have addressed the use of molecular markers as predictive factors for chemotherapy, the data remain controversial and inconclusive.
There are many proposed serological and molecular markers as predictive and prognostic indicators of CRC; however, they are not widely accepted as providing reliable prognostic information due to a lack of reproducibility, validation and standardization among studies [ 3, 4].
Because TAMs have been linked to CSCs maintenance, 21 we were interested in evaluating the possibility of using the expression of the pancreatic CSCs markers CD44 and CD133 and the TAMs marker CD204 as predictive markers of survival in patients with PDAC after resection.
In the present study, we evaluated platelet activation markers as potential predictive markers of sepsis and of mortality among four commonly encountered populations of patients admitted to ICUs.
A number of abstracts were presented on more conventional tumour markers as both predictive and prognostic factors.
The cycleave PCR technique was simultaneously applied to the detection of BRAF mutation, thought to be an adverse prognostic marker as well as a predictive marker for anti-EGFR therapy.
Therefore, the current results indicate that the combination of those two markers may be applicable as predictive markers to select patients for more aggressive treatment and follow-up.
